Development and Validation of a Novel In Vivo Neutron Activation Analysis Technol
新型体内中子活化分析技术的开发和验证
基本信息
- 批准号:8303563
- 负责人:
- 金额:$ 23.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Millions of workers, including over 500,000 welders employed in the United States, have been exposed to excessive metals. Human and animal studies have strongly linked metal exposure to neurophysiological disorders and neurodegenerative diseases. Manganese (Mn) is one of the most significant metal neuro- toxicants among workers. Many occupational studies have documented Mn toxicity. However, the threshold of Mn exposure, the mechanism of the toxicity of Mn, and the interaction of Mn with other metals (such as lead and mercury) are unknown and therefore deserve further investigation. One pending issue in assessment of Mn exposure pertains to the selection of proper biomarker. Over 40% of Mn in human body is stored in bone, which renders bone Mn to be the ideal biomarkers to assess cumulative Mn in the body with long-term, low dose exposure, a pattern typically seen among workers occupationally exposed to Mn. In this project, a novel neutron activation analysis technology will be developed to noninvasively quantify Mn in bone in vivo. Later we will apply this technology in a larger project to study the possible synergistic neurotoxic effect of the exposure of metal mixtures among worker populations. Our central hypothesis to be tested in this proposal is that a novel transportable neutron activation analysis technology can be developed and validated for non invasive in vivo quantification of Mn in bone. We will conduct a series of Monte Carlo simulations to select the best design of the system, set up the system based on the chosen design, optimize the design with experiments, and develop new algorithms to analyze the data and calibrate the system. At the completion of this project, a novel technology for cumulative Mn exposure assessment will be established. The new technology and knowledge will help to fill the data gaps regarding appropriate individual exposure assessment of metals and to provide valuable information on early diagnose of Mn exposure and toxicity. The use of new biomarker to understand the neurotoxic effects of exposure to Mn is critical to millions of workers who have been exposed to Mn for two main reasons. First, neurophysiological disorder is one of the main health issues for these workers; second, neurological impairment reduces the workers' productivity and is a major cause for work related injuries. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
PUBLIC HEALTH RELEVANCE: The proposed research is relevant to occupation health because it addresses a critical problem regarding the development and validation of a novel technology to assess cumulative exposure to one of the most significant metal neuro-toxicants, manganese, among workers. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page
描述(由申请人提供):数百万工人,包括在美国雇用的50多万焊工,暴露于过量的金属。人类和动物研究已经将金属暴露与神经生理障碍和神经退行性疾病紧密联系起来。锰(Mn)是工人最重要的金属神经毒物之一.许多职业研究都记录了锰毒性。然而,锰暴露的阈值,锰的毒性机制,以及锰与其他金属(如铅和汞)的相互作用是未知的,因此值得进一步研究。锰暴露评估中的一个悬而未决的问题是选择合适的生物标志物。人体中超过40%的Mn储存在骨骼中,这使得骨Mn成为评估长期低剂量暴露的体内累积Mn的理想生物标志物,这是职业暴露于Mn的工人中常见的模式。在本项目中,将开发一种新的中子活化分析技术来无创地定量体内骨中的Mn。稍后,我们将在一个更大的项目中应用这项技术,研究工人群体接触金属混合物可能产生的协同神经毒性效应。我们的中心假设是测试在这个建议是一种新的可运输的中子活化分析技术可以开发和验证的非侵入性体内定量骨中的锰。我们将进行一系列的蒙特卡罗模拟来选择系统的最佳设计,根据所选的设计建立系统,通过实验优化设计,并开发新的算法来分析数据和校准系统。该项目完成后,将建立一种新的累积锰暴露评估技术。新的技术和知识将有助于填补适当的个人金属接触评估方面的数据空白,并为锰接触和毒性的早期诊断提供有价值的信息。使用新的生物标志物来了解锰暴露的神经毒性效应对于数百万暴露于锰的工人至关重要,主要有两个原因。首先,神经生理障碍是这些工人的主要健康问题之一;其次,神经损伤降低了工人的生产力,是工伤的主要原因。PHS 398/2590(Rev.06/09)
公共卫生相关性:拟议的研究与职业健康有关,因为它解决了一个关键问题,即开发和验证一种新技术,以评估工人中最重要的金属神经毒物锰的累积暴露。PHS 398/2590(Rev.06/09)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda H Nie其他文献
Linda H Nie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda H Nie', 18)}}的其他基金
Validation of Portable XRF for In Vivo Measurement of Heavy Metal Exposures
便携式 XRF 体内重金属暴露测量的验证
- 批准号:
9057038 - 财政年份:2015
- 资助金额:
$ 23.22万 - 项目类别:
Bone Manganese as a Biomarker for Early Diagnosis of Manganese Neurotoxicity in O
骨锰作为 O 中锰神经毒性早期诊断的生物标志物
- 批准号:
8772785 - 财政年份:2014
- 资助金额:
$ 23.22万 - 项目类别:
Development and Validation of a Novel In Vivo Neutron Activation Analysis Technol
新型体内中子活化分析技术的开发和验证
- 批准号:
8529220 - 财政年份:2012
- 资助金额:
$ 23.22万 - 项目类别:
相似海外基金
Development and validation of a highly novel teleassistance enabled navigational aid for blind persons.
开发和验证了一种高度新颖的远程协助,为盲人提供导航帮助。
- 批准号:
10093029 - 财政年份:2024
- 资助金额:
$ 23.22万 - 项目类别:
Collaborative R&D
TRALSPEC-AI |Development and validation of a novel method for the determination of Tropane Alkaloids in Food and Food Products
TRALSPEC-AI |食品和食品中托烷生物碱测定新方法的开发和验证
- 批准号:
EP/X021610/1 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
Fellowship
Development and validation of a novel point-of-care technology for rapid non-targeted identification of emerging opioid and other drug threats
开发和验证一种新型即时护理技术,用于快速非靶向识别新出现的阿片类药物和其他药物威胁
- 批准号:
10775250 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
Development, Clinical Validation, and Readiness for Implementation of a Novel Mp1p D4 Poin Diagnosis of Talaromycosist of Care Test for Rapid
新型 Mp1p D4 点诊断踝部真菌护理测试的开发、临床验证和准备实施
- 批准号:
10700281 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
Development and validation of novel mouse models and expression vectors for characterizing severe alpha-thalassemia pathophysiology and evaluating gene therapy approaches.
开发和验证新型小鼠模型和表达载体,用于表征严重α-地中海贫血病理生理学和评估基因治疗方法。
- 批准号:
10659630 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
SBIR Phase I: Development of an Optical Biosensor to Facilitate Screening, Validation, and Development of Novel Drugs and their Biological Targets
SBIR 第一阶段:开发光学生物传感器以促进新药及其生物靶点的筛选、验证和开发
- 批准号:
2129469 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Standard Grant
Clinical Development and Validation of a Novel Optical Facebow based on Deep Learning
基于深度学习的新型光学面弓的临床开发和验证
- 批准号:
10036298 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Collaborative R&D
Development and Validation of a Novel Rat Model of Fibromyalgia
新型纤维肌痛大鼠模型的开发和验证
- 批准号:
10732604 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Development and validation of novel optical methods for direct screening of taste receptor activation
直接筛选味觉受体激活的新型光学方法的开发和验证
- 批准号:
10593556 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Development and Validation of a Novel Rat Model of Fibromyalgia
新型纤维肌痛大鼠模型的开发和验证
- 批准号:
10434397 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别: